Attapon Cheepsattayakorn1* and Ruangrong Cheepsattayakorn2*
110th Zonal Tuberculosis and Chest Disease Center, Chiang Mai, Thailand
2Department of Pathology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand
*Corresponding Author: Attapon Cheepsattayakorn, 10th Zonal Tuberculosis and Chest Disease Center, Chiang Mai, Thailand.
Received: April 25, 2020; Published: June 16, 2020
During viral infection, cytokines play an important role in immunopathology with the first line of defense against viral infection via rapid and well-coordinated innate immune response. In vitro studies reveal that delayed release of cytokines and chemokines occurs in respiratory epithelial cells, macrophages and dendritic cells (DCs) at the early stage of severe-acute-respiratory-syndrome coronavirus (SARS-CoV) infection, including COVID-19 infection. At the later stage of infection, these cells secrete low levels of the antiviral factors-interferons (IFNs) and high levels of proinflammatory cytokines (interleukin (IL)-1β, IL-6, and tumor necrosis factor (TNF) and chemokines (C-C motif chemokine ligand (CCL-2, CCL-3 and CCL-5.
Citation: Attapon Cheepsattayakorn and Ruangrong Cheepsattayakorn. “Cytokine Storming in COVID-19". Acta Scientific Microbiology 3.7 (2020): 27.
Copyright: © 2020 Attapon Cheepsattayakorn and Ruangrong Cheepsattayakorn. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Open Access by
Acta Scientific is licensed under a Creative Commons Attribution 4.0 International License
Based on a work at https://actascientific.com
ff
